YB4-21690-01237
2 vaccinations
3 coded responses
11 check-ins
0 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 432 / OH
- Registered
- 2023-03-10
- Relationship
- Child or adolescent in my care
- Guardian
- URQ-10258-32422
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2023-01-18
Dose 1 — Pfizer-BioNTech
-
2023-03-08
Dose 2 — Pfizer-BioNTech
-
2023-03-10
Registered in v-safe
-
2023-03-10
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
- 2023-03-11
- 2023-03-12
- 2023-03-14
- 2023-03-15
- 2023-03-22
-
2023-03-29
Survey response — day 21, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11
-
2023-04-05
Survey response — day 28, dose 2, under 3MedDRA: Cough, Pyrexia — Feeling: GoodMedDRA releases: 2024-11
- 2023-04-12
-
2023-04-19
Survey response — day 42, dose 2, under 3MedDRA: Hand-foot-and-mouth disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-06-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2023-01-18 | Pfizer-BioNTech | No |
| 2 | 2023-03-08 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release